Position in AKBA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$39,438
New position
Shares Held
28,373
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ROYCE & ASSOCIATES LP holds $63,128,523 across 14 Drug Manufacturers - Specialty & Generic names. AKBA ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
229,939 | $11,885,546 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
469,916 | $11,245,089 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
157,126 | $9,312,858 | |
| 4 | COLL |
Collegium Pharmaceutical, Inc
|
272,786 | $9,021,033 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
406,175 | $7,956,968 | |
| 6 | SIGA |
Siga Technologies Inc
|
667,646 | $3,571,906 | |
| 7 | TKNO |
Alpha Teknova, Inc.
|
1,069,162 | $3,089,878 | |
| 8 | ALKS |
Alkermes plc.
|
55,683 | $1,968,950 |
All Filings in AKBA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39,438 | 28,373 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||